Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SuturTek was a medical device company that developed and commercialized automated suturing systems to enhance surgical precision and safety. The company's core technology, the 360° Suturing Device, was designed to mimic the natural motion of a surgeon's hand while providing mechanical advantages in difficult-to-reach anatomical areas. These devices were utilized in both open and laparoscopic procedures to improve the speed and consistency of tissue approximation. SuturTek's innovations aimed to reduce the risk of needle-stick injuries to medical staff and improve patient outcomes through more secure wound closure. The company was acquired by C. R. Bard in 2006 to bolster its surgical specialties portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SuturTek.